Telemedicine Helped Ensure Essential Type 2 Diabetes Care Amid the COVID-19 Pandemic

A new study from the University of Eastern Finland indicates that the COVID-19 pandemic has seriously affected healthcare service usage among patients with 2 type diabetes in North Karelia, Finland, but essential care was continuously provided. The delivery of many essential services was facilitated by processes that strongly relied on telemedicine already before the pandemic.

The outbreak of COVID-19 has challenged healthcare systems and their ability to deliver essential health services. While social distancing measures avoided spreading the virus, they conflicted with good diabetes management, which requires regular follow-up visits to manage the disease and its complications.

In Finland, the government imposed a national lockdown on 16 March, lasting until mid-May 2020. This study used electronic health records to compare healthcare usage in the region of North Karelia in three different periods in 2020 - before, during, and after the lockdown - with the equivalent period in 2019.

In 2020, type 2 diabetes patients sought significantly fewer diabetes- and dental health-related primary healthcare services than the year before the pandemic, with the most significant reduction during the lockdown period. Emergency visits in specialized care dropped significantly during the lockdown period as well, but quickly recovered during the post-lockdown period, reaching the same volume as in 2019.

The high proportion of patients using remote services for diabetes management cushioned the drastic decline in face-to-face appointments - also among elderly patients aged 70 years or older. The proportion of remote consultation among all diabetes-related contacts increased from 56% before the pandemic to 88% during the lockdown period in 2020. Therefore, overall contacts were only 9% fewer in 2020 compared with 2019, while appointments halved.

"The pandemic has highlighted the importance of digital healthcare solutions," says Early Stage Researcher Laura Inglin from the University of Eastern Finland. "In Finland, patients have been able to receive new prescriptions, referrals for examinations, medical opinions, self-care instructions, and lifestyle guidance to monitor and control long-term diseases remotely already for some time. That was a great asset during the pandemic."

"Another asset of Finnish healthcare are high-quality electronic health records, which provide structured and up-to-date information about patients at the point of care. Using routine care data for research helps advance our collective knowledge of health system response to pandemics for future preparedness," Inglin points out.

Inglin L, Wikström K, Lamidi ML, Laatikainen T.
The adverse effect of the COVID-19 pandemic on health service usage among patients with type 2 diabetes in North Karelia, Finland.
BMC Health Serv Res. 2022 Jun 1;22(1):725. doi: 10.1186/s12913-022-08105-z

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...